Form 4: Senti Biosciences Director James J. Collins Acquires Stock Options
SEC Form 4 Filing
Director James J. Collins reports acquisition of stock options in Senti Biosciences.
Summary
- On July 10, 2024, James J. Collins, a director of Senti Biosciences, Inc. (SNTI), acquired 62,500 stock options with an exercise price of $0.31.
- These options vest upon the earlier of the first anniversary of the grant date or the date of the 2025 Annual Meeting, contingent on continued service.
- Following the transaction, Collins directly owns 62,500 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock option acquisition by a director, which can be seen as a mild positive, but doesn't provide strong indications of future performance.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company insiders.
Stakeholder Impact
- Shareholders may view the acquisition of stock options by a director as a sign of confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 07/10/2024 | Date of the transaction: James J. Collins acquired stock options. |
| 2025 Annual Meeting | Vesting date of the options, contingent on continued service, is the earlier of the first anniversary of the grant date or the date of the 2025 Annual Meeting. |
| 07/09/2034 | Expiration date of the stock options. |
| 07/12/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.